About Kevin O'Boyle
Kevin O'Boyle is a director at Carlsmed.
Kevin O'Boyle reports to the SEC as a director or officer of 10 public companies, including Outset Medical (OM), iRhythm (IRTC) and Nevro (NVRO).
Kevin O'Boyle first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin O'Boyle in the role, so the role may have started earlier or lasted longer.
OI
Outset Medical, Inc.
Director
2025 – 2026 · Public company (OM)
II
iRhythm Holdings, Inc.
Director
2025 – 2026 · Public company (IRTC)
NC
Nevro Corp.
Director
2019 – 2025 · Public company (NVRO)
SI
Sientra, Inc.
Director
2014 – 2022 · Public company (SIEN)
GI
GenMark Diagnostics, Inc.
Director
2010 – 2021 · Public company (GNMK)
WV
Wright Medical Group N.V.
Director
2011 – 2020 · Public company (WMGI)
ZI
Zeltiq Aesthetics Inc
Director
2011 – 2017 · Public company (ZLTQ)
DI
Durata Therapeutics, Inc.
Director
2012 – 2014 · Public company (DRTX)
NI
Nuvasive Inc.
CFO and Executive VP
2006 – 2009 · Public company (NUVA)
Key Colleagues at Startups
The people Kevin O'Boyle works with at each company, as listed on that company's latest Form D.
Carlsmed, Inc. · Form D/A, Feb 7, 2025
RM
Robert Mittendorff
Director
LG
Leonard Greenstein
Executive officer
DS
Durall Scott
Executive officer
NC
Niall Casey
Executive officer and director
PY
Philip Young
Director
MC
Michael Cordonnier
Chief Executive Officer and director
KS
Kevin Sidow
Director
SS
Sharon Schulzki
Executive officer
SH
Shariq Hussain
Executive officer
JR
Jonathan Root
Director